Clinical Trial Update: Randomized Controlled Trial of Lipid Apheresis in Patients With Elevated Lipoprotein(a) [NA]

View source ↗

Summary

This randomized controlled trial evaluating lipid apheresis for patients with elevated lipoprotein(a) and progressive cardiovascular disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipoproteinemia
• Progressive Cardiovascular Disease

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Hyperlipoproteinemia(a), Progressive Cardiovascular Disease | NA | Status: WITHDRAWN